Not much sense debating with them, any sensible rebuttal is either ignored or they will just keep spouting off the same chart to suit their narrative or now conspiracy theories about the cure for cancer. We get it Jarrod, you’re bearish on RAC, no worries. I’d at least respect them if they acknowledged when they got things wrong but hey humility is seldom seen on these forums.
Bisantrene is not the magical cure for cancer nor has RAC stated this, or does any rational investor here believe this. What Bisantrene or RAC hopes to achieve is to make chemotherapy safer and more effective. We’re on the doorstep of finding out if this hypothesis (MOPACS) has legs, albeit several months away however closer than we’ve ever been. Let’s also not forget the r/r aml opportunity either.
My pie in the sky hope between now and 1b readouts is there is some sort of partnering with a larger player that has the means to explore more of the Bisantrene opportunity and shoulder some of the risk/funding. I’m happy with giving away some of the upside if it means we can accelerate and actually explore more. It’s also better to have a portion or percentage of something than 100% of nothing. Food for thought, have a great week!
RAC Price at posting:
92.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)